Women have good reason to be confused by continued interpretation of the Women's Health Initiative (WHI) study on the risks and benefits of hormone replacement therapy.
The Wall Street Journal today offers an interesting inside look at how the initial findings were communicated by the National Institutes of Health (NIH).
Excerpt: "... critics including some of the WHI's own investigators, speaking out for the first time, say that NIH officials initially overgeneralized in large part because they excluded many of the study's own investigators and physicians from the first review. As a result, key questions that could have clarified the data far sooner weren't asked."
Posted by schwitz at July 9, 2007 08:21 AM | TrackBack